Skip to main content

Advertisement

Log in

Predictors of survival in surgically treated patients of spinal metastasis

  • Original Article
  • Published:
Indian Journal of Orthopaedics Aims and scope Submit manuscript

Abstract

Background: The spinal metastasis occurs in up to 40% of cancer patient. We compared the Tokuhashi and Tomita scoring systems, two commonly used scoring systems for prognosis in spinal metastases. We also assessed the different variables separately with respect to their value in predicting postsurgical life expectancy. Finally, we suggest criteria for selecting patients for surgery based on the postoperative survival pattern.

Materials and Methods: We retrospectively analyzed 102 patients who had been operated for metastatic disease of the spine. Predictive scoring was done according to the scoring systems proposed by Tokuhashi and Tomita. Overall survival was assessed using Kaplan—Meier survival analysis. Using the log rank test and Cox regression model we assessed the value of the individual components of each scoring system for predicting survival in these patients.

Result: The factors that were most significantly associated with survival were the general condition score (Karnofsky Performance Scale) (P=.000, log rank test), metastasis to internal organs (P=.0002 log rank test), and number of extraspinal bone metastases (P=.0058). Type of primary tumor was not found to be significantly associated with survival according to the revised Tokuhashi scoring system (P=.9131, log rank test). Stepwise logistic regression revealed that the Tomita score correlated more closely with survival than the Tokuhashi score.

Conclusion: The patient’s performance status, extent of visceral metastasis, and extent of bone metastases are significant predictors of survival in patients with metastatic disease. Both revised Tokuhashi and Tomita scores were significantly correlated with survival. A revised Tokuhashi score of 7 or more and a Tomita score of 6 or less indicated >50% chance of surviving 6 months postoperatively. We recommend that the Tomita score be used for prognostication in patients who are contemplating surgery, as it is simpler to score and has a higher strength of correlation with survival than the Tokuhashi score.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Abrams HL, Spiro R, Goldstein N. Metastases in carcinoma: Analysis of 1000 autopsied cases. Cancer 1950;3:74–85.

    Article  CAS  Google Scholar 

  2. Fornasier VL, Horne JG. Metastases to the vertebral column. Cancer 1975;36:590–4.

    Article  CAS  Google Scholar 

  3. Gerszten PC, Welch WC. Current surgical management of metastatic spinal disease. Oncology (Williston Park) 2000;14:1013–24.

    CAS  Google Scholar 

  4. Hatrick NC, Lucas JD, Timothy AR, Smith MA. The surgical treatment of metastatic disease of the spine. Radiother Oncol 2000;56:335–9.

    Article  CAS  Google Scholar 

  5. Klimo P Jr, Kestle JR, Schmidt MH. Clinical trials and evidencebased medicine for metastatic spine disease. Neurosurg Clin N Am 2004;15:549–64.

    Article  Google Scholar 

  6. Maranzano E, Trippa F, Chirico L, Basagni ML, Rossi R. Management of metastatic spinal cord compression. Tumori 2003;89:469–71.

    Article  Google Scholar 

  7. Tokuhashi Y, Kawano H, Ohsaka S, Matsuzaki H, Toriyama S. A scoring system for preoperative evaluation of the prognosis of metastatic spine tumor prognosis. J Jpn Orthop Assoc 1989;63:482–9.

    CAS  Google Scholar 

  8. Karnofsky DA. Clinical evaluation of anticancer drugs: Cancer chemotherapy. GANN Monogr 1967;2:223–31.

    Google Scholar 

  9. Citrin DL, Hougen C, Zweibei W, Schlise S, Pruitt B, Ershler W. The use of serial bone scans inassessing response of bone metastases to systemic treatment. Cancer 1981;47:680–5.

    Article  CAS  Google Scholar 

  10. Swenerton KD, Legha SS, Smith T, Hortobagyi GN, Gehan EA, Yap HY. Prognostic factors in metastaticbreast cancer treated with combination chemotherapy. Cancer Res 1979;39:1552–62.

    CAS  PubMed  Google Scholar 

  11. Yamashita K, Yonenobu S, Fuji T: Staging of metastatic spinal tumor. Rinsho Seikei Geka 1986;21:445–50.

    Google Scholar 

  12. Tokuhashi Y, Matsuzaki H, Oda H, Oshima M, Ryu J. A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine 2005;30:2186–91.

    Article  Google Scholar 

  13. Tomita K, Kawahara N, Kobayashi T, Yoshida A, Murakami H, Akamaru T. Surgical strategy for spinal metastases. Spine 2001;26:298–306.

    Article  CAS  Google Scholar 

  14. Tokuhashi, Matsuzaki H, Oda H, Oshima M, Ryu J. A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine (Phila Pa 1976) 2005;30:2186–91.

    Article  Google Scholar 

  15. Enkaoua EA, Doursounian L, Chatellier G, Mabesoone F, Aimard T, Saillant G. Vertebral metastases: A critical appreciation of the preoperative prognostic Tokuhashi score in a series of 71 cases. Spine 1987;22:2293–8.

    Article  Google Scholar 

  16. Walker MP, Yaszemski MJ, Kim CW, Talac R, Currier BL. Metastatic disease of the spine: Evaluation and treatment. Clin Orthop Relat Res 2003;415:S165–75.

    Article  Google Scholar 

  17. Kaasa T, Wessel J. The Edmonton Functional Assessment Tool: Further development and validation for use in palliative care. JPalliat Care 2001;17:5–11.

    Article  CAS  Google Scholar 

  18. Nikoletti S, Porock D, Kristjanson LJ, Medigovich K, Pedler P, Smith M. Performance status assessment in home hospice patients using a modified form of the Karnofsky Performance Status scale. J Palliat Med 2000;3:301–11.

    Article  CAS  Google Scholar 

  19. Karnofsky D, Abelmann W, Craver L, Burchenal J. The use of nitrogen mustard in the palliative treatment of cancer. Cancer 1948;1:634–56.

    Article  Google Scholar 

  20. Grainger M, Stirling A, Marks D. validation of Tokuhashi and Tomita prognostic scoring systems in spinal metastases. JBJS(Br) 2004;86-B:SUPP_III, 293.

    Google Scholar 

  21. Ulmar B, Naumann U, Catalkaya S, Muche R, Cakir B, Schmidt R, et al. Prognosis scores of Tokuhashi and Tomita for patients with spinal metastases of renal cancer. Ann Surg Oncol 2007;14:998–1004.

    Article  Google Scholar 

  22. Zeng JC, Song YM, Liu H, Gong Q, Li T, Liu LM, et al. The predictive value of the Tokuhashi revised scoring system for the survival time of patients with spinal metastases. Sichuan Da Xue Xue Bao Yi Xue Ban 2007;38:488–91.

    PubMed  Google Scholar 

  23. Katagiri H, Takahashi M, Wakai K, Sugiura H, Kataoka T, Nakanishi K. Prognostic factors and a scoring system for patients with skeletal metastasis. J Bone Joint Surg Br 2005;87:698–703.

    Article  CAS  Google Scholar 

  24. Ogihara S, Seichi A, Hozumi T, Oka H, Ieki R, Nakamura K, et al. Prognostic factors for patients with spinal metastases from lung cancer. Spine 2006;31:1585–90.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Benjamin Tow.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Padalkar, P., Tow, B. Predictors of survival in surgically treated patients of spinal metastasis. IJOO 45, 307–313 (2011). https://doi.org/10.4103/0019-5413.82333

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/0019-5413.82333

Key words

Navigation